- Need Some advice
- Multiple Myeloma
- Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) fo
- Gmail - Semafore Granted Nearly One Million Dollars to Study SF1126 in Multiple Myelo
- Investigating the measles virus as a tool to kill multiple myeloma
- Multiple myeloma clinical trial closes early
- Multiple myeloma clinical trial closes early based on positive results.
- Revlimid data presented at ASCO stands to change the way physicians treat multiple my
- Transplantation does not benefit patients with refractory myeloma
- New multiple myeloma treatment induced total remission in 33 percent of patients
- Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase I
- Emory researchers identify signaling protein for multiple myeloma
- Stress Hormone May Hasten The Progression Of Certain Blood Cancers
- Oral Drug Sets a New Survival Standard for Bone Marrow Cancer
- 3-drug combination 'extremely promising' as first-line therapy for multiple myeloma
- Stem cells make bone marrow cancer resistant to treatment
- Thalidomide Receives Positive Opinion for Treatment of First-line Multiple Myeloma fr
- Major Study Links Insurance Status To Advanced Stage In Multiple Cancers
- The IMF says journal editorial documents dramatic increase in survival since the 1980
- Myeloma in the brain
- Mayo Clinic study discovers role of DNA methylation in multiple myeloma blood cancer
- Multiple myeloma: a paradigm for translation of the cancer stem cell hypothesis
- Bortezomib-Based Combinations
- Novel Drug Combination Offers New Strategy To Destroy Multiple Myeloma
- Immunomodulatory Agents (IMiDs) and Proteasome Inhibitors in Multiple Myeloma